Immunovant Inc
(IMVT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 114,362 | 131,762 | 127,224 | 113,826 | 114,302 |
| Operating Income | -114,362 | -131,762 | -127,224 | -113,826 | -114,302 |
| Other Income | 5,279 | 5,854 | 7,524 | 7,961 | 3,332 |
| Pre-tax Income | -109,083 | -125,908 | -119,700 | -105,865 | -110,970 |
| Income Tax | 1,552 | 594 | 913 | 584 | 152 |
| Net Income Continuous | -110,635 | -126,502 | -120,613 | -106,449 | -111,122 |
| Net Income | $-110,635 | $-126,502 | $-120,613 | $-106,449 | $-111,122 |
| EPS Basic Total Ops | -0.61 | -0.73 | -0.71 | -0.63 | -0.76 |
| EPS Basic Continuous Ops | -0.61 | -0.73 | -0.71 | -0.63 | -0.76 |
| EPS Diluted Total Ops | -0.61 | -0.73 | -0.71 | -0.63 | -0.76 |
| EPS Diluted Continuous Ops | -0.61 | -0.73 | -0.71 | -0.63 | -0.76 |
| EPS Diluted Before Non-Recurring Items | -0.61 | -0.73 | -0.60 | -0.64 | -0.76 |
| EBITDA(a) | $-114,261 | $-131,657 | $-127,117 | $-113,717 | $-114,203 |